Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Melatonin (N05Ch01), Excluding Prolonged-Release Tablets With An Effective Strength Of 2Mg As Part Of A So-Called Open-House Model.

AOK RHEINLAND-PFALZ SAARLAND - DIE GESUNDHEITSKASSE Germany has Released a tender for Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Melatonin (N05Ch01), Excluding Prolonged-Release Tablets With An Effective Strength Of 2Mg As Part Of A So-Called Open-House Model. in Pharmaceuticals. The tender was released on Apr 17, 2024.

Country - Germany

Summary - Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Melatonin (N05Ch01), Excluding Prolonged-Release Tablets With An Effective Strength Of 2Mg As Part Of A So-Called Open-House Model.

Deadline - Mar 31, 2026

GT reference number - 81002923

Product classification - Medicinal products for the alimentary tract and metabolism